Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Aug. 04, 2012	Jul. 30, 2011
Cash flows from operating activities:
Net income	$ 472,049	$ 683,867
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	82,221	88,092
Amortization of intangibles	74	1,079
Stock-based compensation expense	39,223	38,806
Gain on sale of business	0	(6,500)
Gain on sale of investments	(1,231)	0
Excess tax benefit-stock options	(9,552)	(37,296)
Deferred income taxes	(4,105)	(6,989)
Non-cash portion of special charge	219	0
Other non-cash activity	(1,770)	1,185
Changes in operating assets and liabilities	1,367	(91,875)
Total adjustments	106,446	(13,498)
Net cash provided by operating activities	578,495	670,369
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(6,282,724)	(3,132,633)
Maturities of short-term available-for-sale investments	4,829,822	2,334,311
Sales of short-term available-for-sale investments	337,905	259,385
Proceeds from the sale of investments	1,506	0
Proceeds related to sale of businesses	0	10,000
Additions to property, plant and equipment	(94,665)	(96,665)
Payments for acquisitions, net of cash acquired	(24,158)	(13,988)
Increase in other assets	(915)	(6,683)
Net cash (used for) provided by investing activities	(1,233,229)	(646,273)
Cash flows from financing activities:
Proceeds from long-term debt	0	515,507
Early termination of swap agreements	18,520	0
Term loan repayments	(22,875)	(24,767)
Dividend payments to shareholders	(253,329)	(206,802)
Repurchase of common stock	(139,741)	(247,440)
Net proceeds from employee stock plans	110,728	189,239
Contingent consideration payment	(1,991)	0
(Decrease) increase in other financing activities	(6,744)	365
Excess tax benefit-stock options	9,552	37,296
Net cash (used for) provided by financing activities	(285,880)	263,398
Effect of exchange rate changes on cash	(2,337)	327
Net (decrease) increase in cash and cash equivalents	(942,951)	287,821
Cash and cash equivalents at beginning of period	1,405,100	1,070,000
Cash and cash equivalents at end of period	$ 462,149	$ 1,357,821